4Mura M, Santos CC, Stewart D, et al. Vascular endothelial growth factor and related molecules in acute lung injury [ J ]. Appl Physiol, 2004,97 (5) : 1605-1617.
5Ito Y, Betsuyaku T, Nagai K, et al. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS) induced lung injury [ J ]. Exp Gerontol, 2005,40 ( 4 ) : 315-323.
6Pickkers P, Sprong T, Ejj K, et al. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability [ J ]. Shock,2005,24 (6) :508-512.
二级参考文献10
1Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J ,2005,26:523-548.
2Liu J, Conrad DH, Chow S, et al. Collection devices influence the constituents of exhaled breath condensate. Eur Respir J,2007,30 : 807 -808.
3Prieto L, Ferrer A, Palop J, et al. Differences in exhaled breath condensate PH measemdnts between samples obtained with two commercial devices. Respir Med,2007,101 : 1715-1720.
4Roca O, Gomez-Ollaes S, Cruz M J, et al. Effects of salbutamol on exhaled breath condensate biomarkers in acute lung injury: prospective analysis. Crit Care,2008,12 : R72.
5Moloney ED, Mumby SE, Gajdocsi R, et al. Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. Am J Respir Crit Care Med,2004,169:64- 69.
6Muller WG, Morini F, Eaton S, et al. Safety and feasibility of exhaled breath condensate collection in ventilated infants and children. Eur Respir J ,2006,28:479-485.
